Allosteric coupling from G protein to the agonist-binding pocket in GPCRs

References 34

1. 1.

   Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol. 2002;3(9):639-50.

   Not in our library10.1038/nrm908

2. 2.

   Rasmussen SG, et al. Crystal structure of the β2-adrenergic receptor–Gs protein complex. Nature. 2011;477:549-555.

   Not in our library10.1038/nature10361

3. 3.

   Venter JC, et al. The sequence of the human genome. Science. 2001;291:1304-51.

   Not in our library10.1126/science.1058040

4. 4.

   Sprang SR. G protein mechanisms: insights from structural analysis. Annu Rev Biochem. 1997;66:639-78.

   Not in our library10.1146/annurev.biochem.66.1.639

5. 5.

   Chung K, et al. Conformational changes in the G protein Gs induced by the β2-adrenergic receptor. Nature. 2011;477:611-615.

   Not in our library10.1038/nature10488

6. 6.

   Westfield G, et al. Structural flexibility of the Gαs α-helical domain in the β2-adrenoceptor Gs complex. Proc Natl Acad Sci U S A. 2011;108:16086-16091.

   Not in our library10.1073/pnas.1113645108

7. 7.

   Maguire ME, Van Arsdale PM, Gilman AG. An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor. Mol Pharmacol. 1976;12:335-9.

   Not in our library

8. 8.

   Ross EM, Maguire ME, Sturgill TW, Biltonen RL, Gilman AG. Relationship between the beta-adrenergic receptor and adenylate cyclase. J Biol Chem. 1977;252:5761-75.

   Not in our library

9. 9.

   De Lean A, Stadel JM, Lefkowitz RJ. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem. 1980;255:7108-17.

   Not in our library

10. 10.

    Yao XJ, et al. The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex. Proc Natl Acad Sci U S A. 2009;106:9501-6.

    Not in our library10.1073/pnas.0811437106

11. 11.

    Rasmussen SG, et al. Structure of a nanobody-stabilized active state of the β2-adrenoceptor. Nature. 2011;469:175-80.

    Not in our library10.1038/nature09648

12. 12.

    Irannejad R, et al. Conformational biosensors reveal GPCR signalling from endosomes. Nature. 2013;495:534-538.

    Not in our library10.1038/nature12000

13. 13.

    Lefkowitz R, Williams L. Catecholamine binding to the beta-adrenergic receptor. Proceedings of the National Academy of Sciences. 1977;74:515-519.

    Not in our library10.1073/pnas.74.2.515

14. 14.

    Ring A, et al. Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody. Nature. 2013;502:575-579.

    Not in our library10.1038/nature12572

15. 15.

    Bokoch MP, et al. Ligand-specific regulation of the extracellular surface of a G protein-coupled receptor. Nature. 2010;463:108-12.

    Not in our library10.1038/nature08650

16. 16.

    Kikkawa H, Isogaya M, Nagao T, Kurose H. The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005. Mol Pharmacol. 1998;53:128-34.

    Not in our library10.1124/mol.53.1.128

17. 17.

    Dror RO, et al. Pathway and mechanism of drug binding to G protein-coupled receptors. Proc Natl Acad Sci U S A. 2011;108:13118-23.

    Not in our library10.1073/pnas.1104614108

18. 18.

    Rosenbaum DM, et al. Structure and function of an irreversible agonist-β(2) adrenoceptor complex. Nature. 2011;469:236-40.

    Not in our library10.1038/nature09665

19. 19.

    Warne T, et al. The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor. Nature. 2011;469:241-4.

    Not in our library10.1038/nature09746

20. 20.

    Samama P, Cotecchia S, Costa T, Lefkowitz RJ. A mutation-induced activated state of the beta2-adrenergic receptor: extending the ternary complex model. J Biol Chem. 1993;268:4625-36.

    Not in our library

21. 21.

    Weiss JM, Morgan PH, Lutz MW, Kenakin TP. The cubic ternary complex receptor-occupancy model. I. Model description. J Theor Biol. 1996;178:151-67.

    Not in our library10.1006/jtbi.1996.0139

22. 22.

    Burgisser E, De Lean A, Lefkowitz RJ. Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide. Proc Natl Acad Sci U S A. 1982;79:1732-6.

    Not in our library10.1073/pnas.79.6.1732

23. 23.

    Bylund DB, Gerety ME, Happe HK, Murrin LC. A robust GTP-induced shift in alpha(2)-adrenoceptor agonist affinity in tissue sections from rat brain. J Neurosci Methods. 2001;105:159-66.

    Not in our library10.1016/s0165-0270(00)00358-7

24. 24.

    Prater MR, Taylor H, Munshi R, Linden J. Indirect effect of guanine nucleotides on antagonist binding to A1 adenosine receptors: occupation of cryptic binding sites by endogenous vesicular adenosine. Mol Pharmacol. 1992;42:765-72.

    Not in our library

25. 25.

    Werling LL, Puttfarcken PS, Cox BM. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes. Mol Pharmacol. 1988;33:423-31.

    Not in our library

26. 26.

    Haga K, et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature. 2012;482:547-551.

    Not in our library10.1038/nature10753

27. 27.

    Kruse A, et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature. 2013;504:101-106.

    Not in our library10.1038/nature12735

28. 28.

    Manglik A, et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist. Nature. 2012;485:321-326.

    Not in our library10.1038/nature10954

29. 29.

    Huang W, et al. Structural insights into μ-opioid receptor activation. Nature. 2015;524:315-21.

    Not in our library10.1038/nature14886

30. 30.

    Katrich V, et al. Allosteric sodium in class A GPCR signaling. Trends in Biochem Sci. 2014;39:233-44.

    Not in our library10.1016/j.tibs.2014.03.002

31. 31.

    Kozasa T, Gilman AG. Purification of recombinant G proteins from Sf9 cells by hexahistidine tagging of associated subunits. Characterization of alpha 12 and inhibition of adenylyl cyclase by alpha z. J Biol Chem. 1995;270:1734-41.

    Not in our library10.1074/jbc.270.4.1734

32. 32.

    Whorton MR, et al. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc Natl Acad Sci U S A. 2007;104:7682-7.

    Not in our library10.1073/pnas.0611448104

33. 33.

    White JF, et al. Structure of the agonist-bound neurotensin receptor. Nature. 2012;490:508-513.

    Not in our library10.1038/nature11558

34. 34.

    Krumm BE, White JF, Shah P, Grisshammer R. Structural prerequisites for G protein activation by the neurotensin receptor. Nat Commun. 2015;6:7895-7895.

    Not in our library10.1038/ncomms8895

Cited by papers we hold 7

• Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design · 2021
  No notice
• GPCR activation mechanisms across classes and macro/microscales · 2021
  No notice
• Nanobody-enabled monitoring of kappa opioid receptor states · 2020
  No notice
• Discovering Anti-Cancer Drugs via Computational Methods · 2020
  No notice
• Common activation mechanism of class A GPCRs · 2019
  No notice
• Mini G protein probes for active G protein–coupled receptors (GPCRs) in live cells · 2018
  No notice
• Structural insight into the activation of a class B G-protein-coupled receptor by peptide hormones in live human cells · 2017
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.